Actively Recruiting

Age: 18Years +
All Genders
NCT06889974

Timing of Renal Replacement Therapy Initiation in Tumor Lysis Syndrome

Led by University Hospital, Bordeaux · Updated on 2026-01-09

800

Participants Needed

10

Research Sites

104 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The TENDERS study aims to evaluate the impact of the timing of renal replacement therapy (RRT) initiation on outcomes in patients with tumor lysis syndrome (TLS) and associated acute kidney injury (AKI). The study will compare early versus delayed RRT initiation, examining the effect on renal function at 30 days post-treatment.

CONDITIONS

Official Title

Timing of Renal Replacement Therapy Initiation in Tumor Lysis Syndrome

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 618 years
  • Hospitalized in the ICU between January 1, 2013, and December 31, 2023
  • Diagnosed with a hematologic malignancy or solid tumor requiring chemotherapy
  • Diagnosed with tumor lysis syndrome based on at least two biochemical criteria within 3 days before or 7 days after chemotherapy initiation (e.g., hyperkalemia, hyperphosphatemia, hyperuricemia, hypocalcemia)
Not Eligible

You will not qualify if you...

  • Patient or family opposition to data collection for research purposes
  • Incomplete medical records that prevent data extraction

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 10 locations

1

CHU d'Angers

Angers, France

Withdrawn

2

Hôpital Pellegrin

Bordeaux, France

Actively Recruiting

3

Hôpital la cavale blanche

Brest, France

Actively Recruiting

4

CHU Dupuytren 1

Limoges, France

Withdrawn

5

Hôtel-Dieu

Nantes, France

Actively Recruiting

6

CHR d'Orléans

Orléans, France

Actively Recruiting

7

CH de Pau

Pau, France

Actively Recruiting

8

Centre Urgences-Réanimations

Rennes, France

Actively Recruiting

9

IUCT-O Hopital Purpan

Toulouse, France

Actively Recruiting

10

Hôpital Bretonneau

Tours, France

Actively Recruiting

Loading map...

Research Team

A

Arthur ORIEUX

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here